Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Patent
1987-01-23
1988-08-30
Kight, John
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
424 46, 424434, 514850, 514853, A61K 912, A61K 3101, A61K 4700
Patent
active
047676124
ABSTRACT:
Disclosed is a method for the treatment of allergic rhinitis that manifests itself as rhinorrhea, nasal itching, sneezing, congestion and postnasal drip. The method comprises the administration from a nasal aerosol dispenser an effective amount of micronized triamcinolone acetonide suspended in dichlorodifluoromethane into the nasal cavity of a patient suffering from allergic rhinitis.
REFERENCES:
patent: 4294829 (1981-10-01), Suzuki et al.
patent: 4419352 (1983-12-01), Cox et al.
Hagen Nicholas S.
Lamon Kim D.
Acquah S. A.
Kight John
Rorer Pharmaceutical Corporation
LandOfFree
Triamcinolone acetonide for the treatment of allergic rhinitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triamcinolone acetonide for the treatment of allergic rhinitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triamcinolone acetonide for the treatment of allergic rhinitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2087432